摘要
在目前研究中我们建立一个模型(通过暴露在一个低浓度淀粉样β(25-35)肽(Aβ,2μM)的器官型海马体培养物中而造成的慢性神经损伤)来分析17-β雌二醇(17β-E2,10nM)的时间相关影响。神经元死亡于7天后出现,在前24小时或一起或暴露在Aβ后48小时添加17β-E2可以防止神经元死亡。这个影响是效仿选择性雌激素受体激动剂αPPT(100nM)的。Aβ的治疗导致前突触蛋白和后突触蛋白突触素和PSD95的早期和暂时(16-72h)上升,然后在神经元死亡时(7天)下降,17β-E2可以阻止全过程。在暴露于Aβ中72小时后,突触活性提高(谷氨酸盐含量上升,加快装填和卸载FM1-43-标记的突触小囊泡)。这些影响全被能被17-β-E2阻止。这些数据指出雌激素对早期Aβ-引发的突触损伤的有益作用。
关键词: 17-β雌二醇,阿尔茨海默病,雌激素受体α,突触多动,突触素
Current Alzheimer Research
Title:Early β-Amyloid-induced Synaptic Dysfunction Is Counteracted by Estrogen in Organotypic Hippocampal Cultures
Volume: 13 Issue: 6
Author(s): Sara Merlo, Simona Federica Spampinato, Francisco Capani, Maria Angela Sortino
Affiliation:
关键词: 17-β雌二醇,阿尔茨海默病,雌激素受体α,突触多动,突触素
摘要: In the present study we set up a model of slow progression of neuronal injury by exposing organotypic hippocampal cultures to a low concentration of Amyloid β (25-35) peptide (Aβ, 2 μM) to analyze the time-related effects of 17-β estradiol (17β-E2, 10 nM). Neuronal death occurs after 7 d and is prevented by addition of 17β-E2 24 h prior to, together with or 48 h after exposure to Aβ. This effect is mimicked by selective ERα agonist PPT (100 nM). Treatment with Aβ leads to early and transient (16-72 h) increase of pre- and post-synaptic proteins synaptophysin and PSD95, followed by a decrease coincident with neuronal death (7d), all prevented by 17β-E2. At 72 h of Aβ exposure, synaptic activity is increased, as by higher levels of glutamate and increased loading and unloading of FM 1-43-labeled synaptic vesicles. All these effects are also prevented by 17β-E2. These data point out beneficial effects of estrogen on early Aβ-induced synaptic disruption.
Export Options
About this article
Cite this article as:
Sara Merlo, Simona Federica Spampinato, Francisco Capani, Maria Angela Sortino , Early β-Amyloid-induced Synaptic Dysfunction Is Counteracted by Estrogen in Organotypic Hippocampal Cultures, Current Alzheimer Research 2016; 13 (6) . https://dx.doi.org/10.2174/1567205013666160125113509
DOI https://dx.doi.org/10.2174/1567205013666160125113509 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Altered Glial Plasticity in Animal Models for Mood Disorders
Current Drug Targets Traversing the Skin Barrier with Nano-emulsions
Current Drug Delivery Hemodynamic Monitoring in the Acute Management of Pediatric Heart Failure
Current Cardiology Reviews Molecular Modeling of Human BAD, a Pro-Apoptotic Bcl-2 Family Member, Integrating Glycolysis and Apoptosis
Protein & Peptide Letters Systems Biology: A Powerful Tool for Drug Development
Current Topics in Medicinal Chemistry Anti-Amyloid Effects of Small Molecule Aβ-Binding Agents in PS1/APP Mice
Letters in Drug Design & Discovery Calcium Related Genes in Dogs as Potential Cardiac Biomarkers for the Detection of Chronic Mitral Valve Disease
Recent Patents on Biomarkers Specific Targeted Therapy: A New Tool for the Destruction of Cancer
Current Drug Therapy Scientific and Clinical Challenges in Sepsis
Current Pharmaceutical Design Human Anthrax as a Re-Emerging Disease
Recent Patents on Anti-Infective Drug Discovery <i>Lantana undulata</i> Schrank – A New Source of Biological Potential in the Verbenaceae Family
The Natural Products Journal Estrogen, Neuroprotection and Neurogenesis after Ischemic Stroke
Current Drug Targets The Impact of Hypothermia on the Pharmacokinetics of Drugs Used in Neonates and Young Infants
Current Pharmaceutical Design Gap Junctions as Therapeutic Targets in Brain Injury Following Hypoxia- Ischemia
Recent Patents on CNS Drug Discovery (Discontinued) Side Effects of AAS Abuse: An Overview
Mini-Reviews in Medicinal Chemistry Can Decision Making Research Provide a Better Understanding of Chemical and Behavioral Addictions?
Current Drug Abuse Reviews The Protective Effects and Mechanism of Resveratrol-loaded Nanoparticles on HK-2 Cells Suffering from Hypoxia-reoxygenayion
Current Signal Transduction Therapy Recent Patents on Mesenchymal Stem Cell Mediated Therapy in Inflammatory Diseases
Recent Patents on Inflammation & Allergy Drug Discovery Combining Bevacizumab with Radiation or Chemoradiation for Solid Tumors: A Review of the Scientific Rationale, and Clinical Trials
Current Angiogenesis (Discontinued) Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A Review
Current Pharmaceutical Biotechnology